These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. An update on new and emerging therapies for relapsing-remitting multiple sclerosis. Weinstock-Guttman B Am J Manag Care; 2013 Nov; 19(17 Suppl):s343-54. PubMed ID: 24494635 [TBL] [Abstract][Full Text] [Related]
7. Balancing the benefits and risks of disease-modifying therapy in patients with multiple sclerosis. Sørensen PS J Neurol Sci; 2011 Dec; 311 Suppl 1():S29-34. PubMed ID: 22206763 [TBL] [Abstract][Full Text] [Related]
8. New FDA-Approved Disease-Modifying Therapies for Multiple Sclerosis. English C; Aloi JJ Clin Ther; 2015 Apr; 37(4):691-715. PubMed ID: 25846320 [TBL] [Abstract][Full Text] [Related]
9. New treatments and treatment goals for patients with relapsing-remitting multiple sclerosis. Fox EJ; Rhoades RW Curr Opin Neurol; 2012 Feb; 25 Suppl():S11-9. PubMed ID: 22398660 [TBL] [Abstract][Full Text] [Related]